This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Opko Health Is What the Doctor Ordered

NEW YORK ( TheStreet) -- Value investors do it buying stocks they think have a greater intrinsic value than what they are trading at today.

Momentum investors do it buying stocks that are in uptrends and hanging with them as long as they remain in that uptrend.

Technicians believe that a chart says it all.

There is every kind of investing style out there and yet I believe in combining all of these tools into one big grade and comparing against all the other stocks out there.

My style of investing combines performance, valuation, technical analysis and also knowing where the big picture of the market is at any given time.

The big picture of the market right now continues to favor American, small and midcap stocks and, in particular, stocks that are medical or pharmaceutical related.

Opko Health (OPK - Get Report) is one such stock that fits this bill and it is currently ranked the number one stock by my Best Stocks Now! app.

Opko is a $3.7 billion midcap company headquartered in Miami that develops a broad range of pharmaceutical products, diagnostic tests and vaccines.

Already we know this stock has got a lot going for it; it's in the right geographic area (U.S), the right asset class (mid-cap) and the right sector (medical) of the market.

Performance/Momentum: So what about performance? Let's take a look at my Best Stocks Now! app to see how this stock has performed over the years.

Over the last 10 years, even though it has been a bumpy ride, Opko has delivered an average annual return of 36.7% per year while the market delivered 5% per year during the same timeframe.

Over the last five years, again, this stock has been all over the place but overall it has delivered an average of 58.7% to investors while the market has averaged returns of only 11.4%.

Over the last three years, the pace has quickened, and the stock's performance has accelerated. Opko's performance has gotten even better with returns of 69.5% per year all the while the market delivered 13% per year. Over the last 12 months while market is up 19.7%, Opko is up a whopping 182%!

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
OPK $14.44 0.00%
AAPL $129.09 0.00%
FB $79.75 0.00%
GOOG $571.34 0.00%
TSLA $197.32 0.00%


DOW 18,288.63 +155.93 0.86%
S&P 500 2,117.39 +12.89 0.61%
NASDAQ 5,008.0960 +44.5690 0.90%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs